A Phase I, Open-Label Trial to Investigate the Pharmacokinetic Interaction Between TMC125 and Two Antifungal Agents (Fluconazole and Voriconazole), All at Steady-State in Healthy Subjects.

Trial Profile

A Phase I, Open-Label Trial to Investigate the Pharmacokinetic Interaction Between TMC125 and Two Antifungal Agents (Fluconazole and Voriconazole), All at Steady-State in Healthy Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Jan 2013

At a glance

  • Drugs Etravirine (Primary) ; Fluconazole; Voriconazole
  • Indications Aspergillosis; Candidiasis; Fusariosis; HIV infections; Mycoses
  • Focus Pharmacokinetics
  • Sponsors Janssen R&D Ireland
  • Most Recent Events

    • 14 Sep 2009 Results were presented at ICAAC, San Francisco, USA, Sept, 2009.
    • 18 Apr 2009 Actual end date (Jan 2009 ) added as reported by ClinicalTrials.gov.
    • 18 Apr 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top